More on ORMP
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.25 |
|
|||
| Open | $2.25 | ||||
| 52 Wk High | $10.74 | ||||
| 52 Wk Low | $5.60 | ||||
| Day High | $2.25 | ||||
| Day Low | $2.25 | ||||
| P/E | N/A | ||||
| EPS | $-0.59 | ||||
| Volume | 56 | ||||
- Form 10-Q ORAMED PHARMACEUTICALS For: Sep 30
- PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization
- Form 8-K ORAMED PHARMACEUTICALS For: Sep 21
- Sorrento Therapeutics (SRNEQ) Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding
- Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Co
- Oramed Pharma (ORMP) Announces $101.88M Short-Term Senior Secured Note Transaction with Scilex Holding Company
- Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company
- Scilex (SCLX) Announces Consummation of Previously Announced Purchase of all Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.
- Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.
- Scilex Holding (SCLX) Enters Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento
Entities mentioned with ORMP
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Unusual 11 Mid-Day Movers | View Related Stories »
- Earnings | View Related Stories »
- S3 | View Related Stories »
- Pre Market Movers | View Related Stories »
- 13G | View Related Stories »
- Show More...
